RA-MAP, Molecular Immunological Landscapes in Early Rheumatoid Arthritis and Healthy Vaccine Recipients

To investigate the peripheral blood immune cell landscape of early, drug naive rheumatoid arthritis (RA), the authors performed comprehensive clinical and molecular profiling of 267 RA patients and 52 healthy vaccine recipients for up to 18 months to establish a high quality sample biobank.